David Mott
board member
Clementia Pharmaceuticals
Canada
Biography
Mr. David M. Mott has served as a general partner of New Enterprise Associates, an investment firm focused on venture capital and growth equity investments, since September 2008, where he leads the healthcare investing practice.
Research Interest
business
